SCHEMBL5486248

SCHEMBL5486248

CCOC(=O)C(C)(C)Oc1ccc(CN(C)C(=O)CCC#Cc2ccc(OC(F)(F)F)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 4/20 0.44
ABCB11 O95342 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44
HTR2A P28223 1/20 0.44
PMP22 Q01453 1/20 0.44
ACACB O00763 2/20 0.39
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
FBP1 P09467 3/20 0.38
POLB P06746 1/20 0.36
LMNA P02545 1/20 0.36
SCN9A Q15858 1/20 0.35
PPARG P37231 2/20 0.35
FFAR1 O14842 1/20 0.35
OPRK1 P41145 1/20 0.35
MEN1 O00255 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5486690 0.90 PPARA (0.44) PPARAACACBSCN9APPARGFFAR1
SCHEMBL5482649 0.83 PPARA (0.44) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL8794052 0.76 PPARA (0.71) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL3881868 0.74 ACACB (0.43) CYP1A2CYP3A4TSHRACACBALDH1A1
SCHEMBL5486993 0.74 PPARA (0.42) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL5489663 0.73 FBP1 (0.44) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL5483541 0.72 FBP1 (0.43) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL1549827 0.72 PPARA (0.56) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL4576413 0.72 PPARA (0.37) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL5483321 0.72 PPARA (0.50) PPARAACACBLMNAPPARGEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7253192-B2 Phenyl derivatives comprising an acetylene group HOFFMANN-LA ROCHE INC. (US) 2007-08-07 US disclosed
EP-1765760-A1 PHENYL DERIVATIVES COMPRISING AN ACETYLENE GROUP F.HOFFMANN-LA ROCHE AG (CH) 2007-03-28 EP disclosed
WO-2006002802-A1 PHENYL DERIVATIVES COMPRISING AN ACETYLENE GROUP F. HOFFMANN-LA ROCHE AG (CH) 2006-01-12 WO disclosed
US-20060004091-A1 Phenyl derivatives comprising an acetylene group F. HOFFMANN-LA ROCHE AG (CH) 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004091-A1 Phenyl derivatives comprising an acetylene group PPARD, PPARA, PPARG PPARA 2/4885ABCB11 880/4885CYP1A2 82/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.